Inventors with similar research interests:
Company Filing History:
34 out of 125 
11 out of 29 
7 out of 15 
Years Active: 2017-2025
Areas of Expertise:
Title: Innovations by Aleksandra Rudnitskaya
Introduction
Aleksandra Rudnitskaya is a prolific inventor based in Roslindale, MA, USA. With an impressive portfolio of 50 patents, she has made significant contributions to the field of biochemistry, particularly in the development of innovative therapies for cancer and other diseases.
Latest Patents
Rudnitskaya's latest patents include groundbreaking work on alpha-cinnamide compounds and compositions that act as HDAC8 inhibitors. This invention focuses on inhibitors of histone deacetylases, particularly HDAC8, which are instrumental in treating cancer and a variety of other disorders. Another notable patent is for 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids, which serve as inhibitors of zinc-dependent histone deacetylases. This innovation is relevant for the treatment of diseases associated with HDAC, like HDAC6.
Career Highlights
Throughout her career, Aleksandra has worked with esteemed companies such as Forma Therapeutics, Inc. and Valo Health, Inc. These roles provided her with a robust platform to further her research and development in the medical and pharmaceutical sectors.
Collaborations
Rudnitskaya has collaborated with numerous talented professionals, including her coworkers Pui Yee Ng and Xiaozhang Zheng. These partnerships have likely fostered innovative ideas and effective solutions in their shared field of expertise.
Conclusion
Aleksandra Rudnitskaya serves as an exemplary figure in the realm of patent innovation. Her extensive portfolio and contributions to HDAC inhibition reflect her commitment to advancing medical science, ensuring her place among the notable inventors in her field.